Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 43 of 410 for:    ARIPIPRAZOLE

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01411930
Recruitment Status : Completed
First Posted : August 8, 2011
Last Update Posted : December 20, 2012
Bristol-Myers Squibb
Information provided by (Responsible Party):
Jonathan M. Meyer, MD, Veterans Medical Research Foundation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2010
Actual Study Completion Date : August 2011